Mesonephric-like Adenocarcinoma Arising from the Ovary: A Case Review and Treatment Considerations

Main Article Content

Yu Horibe
Toshiyuki Kanno
Takashi Motohashi
Yoshika Akizawa
Hiroshi Funamoto
Tsutomu Tabata

Abstract

Mesonephric-like adenocarcinomas (MLAs) are a rare classification of pathologic cancers. These clinically high-grade cancers exhibit a distinct propensity for distant metastasis, notably in the lungs, often diagnosed at advanced stages (II–IV) according to The International Federation of Gynecology and Obstetrics (FIGO), and clinical course is unclear. A 62-year-old woman was diagnosed as a left ovarian tumor, magnetic resonance imaging (MRI) revealed a 68 mm nodule confined to the left ovary with no evidence of pelvic cavity invasion. After surgery, the patient was diagnosed with FIGO stage IIIA1(ii) mesonephric-like adenocarcinoma. Homologous recombination deficiency (HRD) status and breast cancer 1/2 (BRCA1/2) were negative. Postoperatively, the patient received six sessions of taxotere and cyclophosphamide (TC) chemotherapy as an adjuvant chemotherapy with no recurrent lesions. There are few reports that the positive rate of HRD score and the efficacy of poly adenosine diphosphate (ADP) - ribose polymerase inhibitors (PARPi) remain unclear. Adjuvant chemotherapy using carboplatin and paclitaxel after complete surgery has shown promising results with a low risk of recurrence. Further accumulation of cases and studies on regimens, including long-term prognosis and maintenance therapy are needed.

Article Details

How to Cite
(1)
Horibe, Y.; Kanno, T.; Motohashi, T.; Akizawa, Y.; Funamoto, H.; Tabata, T. Mesonephric-Like Adenocarcinoma Arising from the Ovary: A Case Review and Treatment Considerations. Thai J Obstet Gynaecol 2024, 32, 314-319.
Section
Case Report

References

Turashvili G, Lastra R. What’s new in gynecologic pathology 2021: ovary and fallopian tube. J Pathol Transl Med 2021;55:366-7.

Restaino S, Pellecchia G, Tulisso A, Paglietti C, Orsaria M, Andreetta C, Poletto E, et al. Mesonephric-like adenocarcinomas: A rare tumor—the importance of diagnosis. Int J Environ Res Public Health 2022;19:14451.

Ma T, Chai M, Shou H, Ru G, Zhao M. Mesonephric-like adenocarcinoma of uterine corpus: A clinicopathological and targeted genomic profiling study in a single institution. Gynecol Oncol 2022;12:911695.

Buza N. Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors. Semin Diagn Pathol 2022;39:58-77.

Liu Y, Karnezis A. Mesonephric-like adenocarcinoma: Two cases of a rare entity and review of literature. Am J Clin Pathol 2020;154:S59.

Pors J, Segura S, Chiu DS, Almadani N, Ren H, Fix DJ, et al. Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: A multi-institutional study. Am J Surg Pathol 2021;45:498–506.

Koh HH, Park E, Kim HS. Mesonephric-like adenocarcinoma of the ovary: Clinicopathological and molecular characteristics. Diagnostics (Basel) 2022;12:326.

Chen Q, Shen Y, Xie C. Mesonephric-like adenocarcinoma of the ovary: A case report and a review of the literature. Medicine (Baltimore) 2020;99:e23450.

Chang CS, Carney ME, Killeen JL. Two cases of mesonephric-like carcinoma arising from endometriosis: Case report and review of the literature. Int J Gynecol Pathol 2023;42:101-7.

Dundr P, Gregová M, Němejcová K, Bártů M, Hájková N, Hojný J, et al. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: A case report with complex morphological and molecular analysis. Diagn Pathol 2020;15:91.